Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1971 1
1978 2
1981 1
1983 2
1984 3
1985 3
1986 5
1987 3
1988 6
1989 5
1990 7
1991 5
1992 8
1993 3
1994 1
1995 4
1996 5
1997 7
1998 8
1999 8
2000 8
2001 6
2002 9
2003 11
2004 3
2005 9
2006 17
2007 14
2008 10
2009 18
2010 14
2011 11
2012 28
2013 25
2014 28
2015 28
2016 38
2017 25
2018 16
2019 13
2020 20
2021 20
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

407 results
Results by year
Filters applied: . Clear all
Page 1
Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody.
Kanaya N, Kuroda S, Kakiuchi Y, Kumon K, Tsumura T, Hashimoto M, Morihiro T, Kubota T, Aoyama K, Kikuchi S, Nishizaki M, Kagawa S, Tazawa H, Mizuguchi H, Urata Y, Fujiwara T. Kanaya N, et al. Among authors: urata y. Mol Ther. 2020 Mar 4;28(3):794-804. doi: 10.1016/j.ymthe.2020.01.003. Epub 2020 Jan 10. Mol Ther. 2020. PMID: 31991110 Free PMC article.
Involvement of immune cells in the pathogenesis of endometriosis.
Izumi G, Koga K, Takamura M, Makabe T, Satake E, Takeuchi A, Taguchi A, Urata Y, Fujii T, Osuga Y. Izumi G, et al. Among authors: urata y. J Obstet Gynaecol Res. 2018 Feb;44(2):191-198. doi: 10.1111/jog.13559. Epub 2018 Jan 5. J Obstet Gynaecol Res. 2018. PMID: 29316073 Review.
Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
Sugiu K, Tazawa H, Hasei J, Yamakawa Y, Omori T, Komatsubara T, Mochizuki Y, Kondo H, Osaki S, Fujiwara T, Yoshida A, Kunisada T, Ueda K, Urata Y, Kagawa S, Ozaki T, Fujiwara T. Sugiu K, et al. Among authors: urata y. Cancer Chemother Pharmacol. 2021 Sep;88(3):513-524. doi: 10.1007/s00280-021-04310-5. Epub 2021 Jun 10. Cancer Chemother Pharmacol. 2021. PMID: 34114067
407 results